![These highlights do not include all the information needed to use SPRAVATO ® safely and effectively. See full prescribing information for SPRAVATO ®. SPRAVATO ® (esketamine) nasal spray, CIII Initial U.S. Approval: 1970 ( ketamine) These highlights do not include all the information needed to use SPRAVATO ® safely and effectively. See full prescribing information for SPRAVATO ®. SPRAVATO ® (esketamine) nasal spray, CIII Initial U.S. Approval: 1970 ( ketamine)](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=spravato-01.jpg&id=708098)
These highlights do not include all the information needed to use SPRAVATO ® safely and effectively. See full prescribing information for SPRAVATO ®. SPRAVATO ® (esketamine) nasal spray, CIII Initial U.S. Approval: 1970 ( ketamine)
NeuroPsych Wellness Center is accepting new patient inquiries for Spravato ( esketamine) Nasal Spray treatment. Spravato is used to treat treatment... | By NeuroPsych Wellness Center, PC | Facebook
![Janssen Announces U.S. FDA Approval of SPRAVATO™ (esketamine) CIII Nasal Spray for Adults with Treatment-Resistant Depression (TRD) Who Have Cycled Through Multiple Treatments Without Relief Janssen Announces U.S. FDA Approval of SPRAVATO™ (esketamine) CIII Nasal Spray for Adults with Treatment-Resistant Depression (TRD) Who Have Cycled Through Multiple Treatments Without Relief](https://mma.prnewswire.com/media/831191/Janssen_Spravato.jpg?p=facebook)